Product IntroductionBioactivity英文名:
HPGDS inhibitor 2描述: HPGDS inhibitor 2 (GSK-2894631A) 是高效的造血前列腺素 D 合成酶(H-PGDS)选择性抑制剂(IC50:9.9 nM)。
体外活性: GSK2894631A(IC50 = 9.9 nM, LE = 0.42) is a potent, competitive, and reversible inhibitor of H-PGDS. GSK2894631A exhibited good H-PGDS cellular activity (RBL IC50 = 160 nM) in a rat basophilic leukemia (RBL) cell PGD2 production assay.
体内活性: GSK2894631A had a low i.v. clearance (Cl = 5.6 mL/min/kg), moderate i.v. steady state volume of distribution (VSS = 1.7 l/kg), long i.v. terminal half-life (t1/2 = 3.8 hr), and good oral exposure (p.o. DNAUC = 1800 ng/hr/mL, F = 61%) in mice. It attenuated PGD2 production in an acute in vivo murine mast cell degranulation model (ED50 = 0.032 mg/kg, EC50 = 21 nM) of inflammation. Unfortunately, at higher doses (≥10 mg/kg) in a chronic eccentric muscle damage model (vide infra Fig. 6) in mice, 1a-treated animals exhibited seizure-like activity at day four of dosing.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 130mg/ml(343.54mM)
关键字:
HPGDS inhibitor2 |
PGE synthase |
Inhibitor |
inhibit |
HPGDS inhibitor-2 |
HPGDS inhibitor 2 |
Prostaglandin E synthase相关产品:
Dehydroevodiamine |
CAFESTOL |
(S)-Flurbiprofen |
Benzydamine hydrochloride |
ETHYL CAFFEATE |
Sinensetin |
Friluglanstat |
AT-56 |
hPGDS-IN-1 |
Limaprost相关库:
Bioactive Compounds Library Max |
Inhibitor Library |
NO PAINS Compound Library |
Bioactive Compound Library